期刊文献+

132例复发性肝细胞癌病例的生存分析 被引量:3

Analysis on the Survival in 132 Recurrent Cases of Hepatocelluar Carainoma
在线阅读 下载PDF
导出
摘要 目的 研究肝癌复发后的不同治疗方法带来的预后生存的不同。方法 对 2 71例肝癌切除后复发的 132例患者复发情况进行分析 ,同时比较复发后不同治疗方法的结果。结果  6 7%的肿瘤复发位于肝内 ,而且其中近一半是局限性复发 ,这些病例经再次肝切除、经肝动脉插管化疗栓塞或经皮无水酒精注射治疗后 ,5年生存率可达 30 %。同时发现肝移植亦不失为一种好的方法。结论 对于复发性肝细胞肝癌积极的外科治疗可获好的疗效。 Objective To study the reasonable treatment in the recurrence of hepatocellular carcinoma(HCC.)Methoods 132 recurrent cases of hepatocellular carcinoma were analysized by the following factors (host condition,tumor characteristics and surgical procedures from Jan.1983 to Jan.1997), The different surgical treatments in these patients were compared simultaneously.Results 67% of the recurrence were exclusively intrahepatic and half recurrence were limitited in size and number. The survival rate for 5 years was 30% following treatment of limited intrahepatic recurrence by re hepatectomy,arterial chemoembolization or percutaneous ethanol injection,and liver transplantation is needed to obtain better results.Conclusion An aggressive approach to tumor recurrence is the best way to improve the longterm outcome following resection of HCC.
出处 《预防医学情报杂志》 CAS 2000年第2期103-106,共4页 Journal of Preventive Medicine Information
关键词 肝细胞肝癌 复发 治疗 生存分析 Hepatocellular Carcinoma,Recurrence,Treatment
  • 相关文献

参考文献2

  • 1周信达,余业勤,汤钊猷,马曾辰,徐东波,张博恒,郑亚新,翁建茂.冷冻外科治疗肝癌[J].癌症,1993,12(4):315-317. 被引量:13
  • 2Kuo-Shyang Jeng M.D.,Fi-Sh Yang M.D.,Hsein-Jar Chiang M.D.,Ikuho Ohta M.D.. Repeat operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: A comparison with transcatheter arterial chemoembolization[J] 1992,World Journal of Surgery(6):1188~1191

共引文献12

同被引文献17

  • 1丛文铭.复发性肝细胞癌的病理生物学特征[J].中国实用外科杂志,1995,15(5):269-271. 被引量:23
  • 2陈汉,吴孟超.原发性肝癌手术后复发再治疗方法的选择[J].中华医学杂志,1997,77(3):163-164. 被引量:12
  • 3孙德 周际昌.临床胂瘤内科手册(第4版)[M].北京:人民卫生出版社,2003.102-104.
  • 4Carr BI, Selby R, Madariaga J, et al. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transpl Proc, 1993, 25 : 1128-1129.
  • 5Ohhoff KM, Rosove MH, Shackleton CR, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.Arm Surg, 1995, 221:734-743.
  • 6Cherqui D. Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma. J Hep Bil Pancr Surg, 1998, 5 : 35-40.
  • 7Nerenstone SR, lhde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev, 1988, 15: 1-31.
  • 8Yang TS, Wang CH, Hsieh RK, et al. A 2-stage Phase Ⅱ study of gemcitabine and doxorubicin in patients with advanced hepatocellular carcinoma. Proc Annu Meet Am Soc Clin Oncol, 2001, 20: A670.
  • 9Neeleman N,Auderson R.Repeated liver resection for recurrent liver cancer[ J].Br J Surg,1996,83(7):893-901.
  • 10Farges O,Regimbeau JM,Belghiti J.Aggressive managemeat of recurrence following surgical resection of hepatocellular caricinoma[J].Hepatogastroenterology,1998,45(Suppl 3):1275-1280.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部